A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-120101 Administered Intrathecally in Patients with Huntington's Disease.

  • Bertram, Kelly (Primary Chief Investigator (PCI))
  • Burn, Katherine, (Project Manager)

Project: Research

StatusActive
Effective start/end date18/09/1931/10/20

Keywords

  • Neurology
  • Huntington's disease
  • Clinical trial